Typhoidal and non-typhoidal Salmonella infections in Africa

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 12, 2016, Pages 1913-1922

  Smith, S I ^a   Seriki, A ^b   Ajayi, A ^b  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALEXIN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; STREPTOMYCIN; TOXIN;

AFRICA; ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; CLINICAL FEATURE; DIARRHEA; GASTROENTERITIS; GENOMICS; HUMAN; INFLAMMATION; MEDLINE; MULTIDRUG RESISTANCE; NON TYPHOIDAL SALMONELLA INFECTION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; SEROLOGY; TYPHOID FEVER; VACCINATION; CLASSIFICATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MORTALITY; PATHOLOGY; SALMONELLA; SALMONELLA INFECTIONS; TRANSMISSION;

AFRICA; DRUG RESISTANCE, BACTERIAL; HUMANS; SALMONELLA; SALMONELLA INFECTIONS;

EID: 84983453698     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2760-3     Document Type: Review

References (106)

1. (2006) Salmonella. In: Greenwood D, Slack RCB, Peutherer JF (eds) Medical microbiology. A guide to microbial infections, pathogenesis, immunity, laboratory diagnosis and control, 16th edn. Elsevier Science Limited, Churchill Livingstone, pp 250–259
2. Grimont PAD, Weill FX (2007) Antigenic formulae of the Salmonella serovars, 9th edn. World Health Organization Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, France
3. Rotger R, Casadesús J (1999) The virulence plasmids of Salmonella. Int Microbiol 2:177–184
4. Su LH, Chiu CH (2007) Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J 30(3):210–219
5. Pui CF, Wong WC, Chai LC, Robin T, Ponniah J, Sahroni NHM et al (2011) Salmonella: a foodborne pathogen. Int Food Res J 18:465–473
6. Haeusler GM, Curtis N (2013) Non-typhoidal Salmonella in children: microbiology, epidemiology and treatment. Adv Exp Med Biol 764:13–26
7. Bisi-Johnson MA, Obi CL (2012) Escherichia coli and Salmonella species: molecular landscape and therapeutic considerations: a review. Adv Med Sci 1(1):1–16
8. Akyala AI, Alsam S (2015) Extended spectrum beta lactamase producing strains of salmonella species—a systematic review. J Microbiol Res 5(2):57–70
9. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Muyodi J et al (2006) Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission? J Med Microbiol 55:585–591
10. Majowicz SE, Musto J, Scallan E (2010) International collaboration on enteric disease “Burden of Illness” studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50(6):882–889
11. Mandomando I, Macete E, Sigaúque B, Morais L, Quintó L, Sacarlal J et al (2009) Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health 14(12):1467–1474
12. Kariuki S, Okoro C, Kiiru J, Njoroge S, Omuse G, Langridge G et al (2015) Ceftriaxone-resistant Salmonella enterica serotype typhimurium sequence type 313 from Kenyan patients is associated with the blaCTX-M-15 gene on a novel IncHI2 plasmid. Antimicrob Agents Chemother 59:3133–3139
13. Feasey NA, Archer BN, Heyderman RS, Sooka A, Dennis B, Gordon MA et al (2010) Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis 16(9):1448–1451
14. Bahwere P, Levy J, Hennart P, Donnen P, Lomoyo W, Dramaix-Wilmet M et al (2001) Community-acquired bacteremia among hospitalized children in rural central Africa. Int J Infect Dis 5:180–188
15. Tennant SM, Diallo S, Levy H, Livio S, Sow SO, Tapia M et al (2010) Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Negl Trop Dis 4(3):e621
16. Boni-Cissé C, Meité S, Faye-Ketté H, Houedanou C, Timité-Konan M, Kalpi C et al (2012) Serotypes and antibiotypes of Salmonella isolated at the University Teaching Hospital of Yopougon, Abidjan, Côte d’Ivoire from 2005 to 2009. J Microbiol Antimicrob 4(2):40–44
17. Mohamed MEM, Suelam IIA (2010) Isolation of non-typhoid Salmonella from humans and camels with reference to its survival in abattoir effluents. Glob Vet 5(6):356–361
18. Labi AK, Obeng-Nkrumah N, Addison NO, Donkor ES (2014) Salmonella blood stream infections in a tertiary care setting in Ghana. BMC Infect Dis 14:3857
19. Ifeanyi CI, Bassey BE, Ikeneche NF, Al-Gallas N (2014) Molecular characterization and antibiotic resistance of Salmonella in children with acute gastroenteritis in Abuja, Nigeria. J Infect Dev Ctries 8(6):712–719
20. Abdullahi B, Abdulfatai K, Wartu JR, Mzungu I, Muhammad HID, Abdulsalam AO (2014) Antibiotics susceptibility patterns and characterization of clinical Salmonella serotypes in Katsina State, Nigeria. Afr J Microbiol Res 8:915–921
21. Glynn JR, Palmer SR (1992) Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am J Epidemiol 136(11):1369–1377
22. Gal-Mor O, Boyle EC, Grassl GA (2014) Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front Microbiol 5:391
23. Oundo JO, Muli F, Kariuki S, Waiyaki PG, Iijima Y, Berkley J et al (2002) Non-typhi Salmonella in children with severe malaria. East Afr Med J 79(12):633–639
24. Mengistu G, Mulugeta G, Lema T, Aseffa A (2014) Prevalence and antimicrobial susceptibility patterns of Salmonella serovars and Shigella species. J Microbial Biochem Technol S2:006
25. Olowe OA, Okanlawon BM, Olowe RA, Adedosu OT, Olayemi AB (2007) Multiple drug resistant pattern of Salmonella typhimurium infections in Osogbo, South Western Nigeria. J Am Sci 3(4):40–44
26. Akinyemi KO, Bamiro BS, Coker AO (2007) Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones. J Health Popul Nutr 25(3):351–358
27. Reda AA, Seyoum B, Yimam J, Andualem G, Fiseha S, Vandeweerd JM (2011) Antibiotic susceptibility patterns of Salmonella and Shigella isolates in Harar, Eastern Ethiopia. J Infect Dis Immun 3:134–139
28. Lunguya O, Lejon V, Phoba MF, Bertrand S, Vanhoof R, Verhaegen J et al (2012) Salmonella typhi in the Democratic Republic of the Congo: fluoroquinolone decreased susceptibility on the rise. PLoS Negl Trop Dis 6(11):e1921
29. Ishaku AA, Katsa M, Yakubu H, Habibu T, Daniel A, Solomon A (2013) Incidence and antimicrobial resistance pattern of some clinical isolate of Salmonella Typhi in Akwanga, Nasarawa State, Nigeria. J Med Biomed Sci 4:1–5
30. Humphries RM, Fang FC, Aarestrup FM, Hindler JA (2012) In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis 55(8):1107–1113
31. Marshall B, Kadangs C (2014) Public health threat agent: Salmonella. APUA Newsl 32(3):1–21
32. Piddock LJV (2002) Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 26:3–16
33. Adeleye A, Smith S, Akanmu S, Bamiro S, Sobande O, Igbinosum E et al (2008) Chromosomally mediated antibiotic resistance in non-typhoidal Salmonellae isolated from HIV patients in Lagos. West Indian Med J 57(5):519–520
34. Pegues DA, Miller SI (2010) Salmonella species, including Salmonella typhi. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 7th edn. Elsevier, Philadelphia, pp 2887–2903
35. Kagambèga A, Lienemann T, Aulu L, Traoré AS, Barro N, Siitonen A et al (2013) Prevalence and characterization of Salmonella enterica from the feces of cattle, poultry, swine and hedgehogs in Burkina Faso and their comparison to human Salmonella isolates. BMC Microbol 13:253
36. Abbassi-Ghozzi I, Hammami S, Aissa RB, Martinez-Urtaza J, Boudabous A, Gtari M (2012) Pulsed-field gel electrophoresis, plasmid profile and antimicrobial resistance pattern of Salmonella typhimurium isolated from human and retail meats. Afr J Microbiol Res 6(22):4680–4686
37. Morpeth SC, Ramadhani HO, Crump JA (2009) Invasive non-typhi Salmonella disease in Africa. Clin Infect Dis 49:606–611
38. Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, Gordon MA et al (2009) Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19(12):2279–2287
39. Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, Feasey NA et al (2015) Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat Genet 47:632–639
40. Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid fever. Clin Infect Dis 50(2):241–246
41. DeRoeck D, Jodar L, Clemens J (2007) Putting typhoid vaccination on the global health agenda. N Engl J Med 357:1069–1071
42. Threlfall EJ (2002) Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 26:141–148
43. Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82:346–353
44. Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J et al (2010) Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 48(6):2171–2176
45. Reddy EA, Shaw AV, Crump JA (2010) Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:417–432
46. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002) Typhoid fever. N Engl J Med 347(22):1770–1782
47. Whitaker JA, Franco-Paredes C, del Rio C, Edupuganti S (2009) Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 16:46–52
48. Smith SI, Agomo CO, Bamidele M, Opere BO, Aboaba OO (2010) Survey of food handlers in Bukas (a type of local restaurant) in Lagos, Nigeria about typhoid fever. Health 2(08):951–956
49. Buckle GC, Walker CL, Black RE (2012) Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2(1):010401
50. Srikantiah P, Girgis FY, Luby SP, Jennings G, Wasfy MO, Crump JA et al (2006) Population-based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg 74(1):114–119
51. Sory E (2009) The health sector in Ghana. Facts and figures. Ghana Health Service, Accra, Ghana, p 31
52. Marks F, Adu-Sarkodie Y, Hünger F, Sarpong N, Ekuban S, Agyekum A et al (2010) Typhoid fever among children, Ghana. Emerg Infect Dis 16(11):1796–1797
53. Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB et al (2012) Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS One 7(1):e29119
54. Uttah EC, Osim SE, Etta H, Ogban E, Okon NEE (2013) Four-year longitudinal assessment of the prevalence of typhoid fever among those attending the General Hospital Etinan, Nigeria. Int J Sci Res Pub 3(7):150–153
55. Malisa A, Nyaki H (2010) Prevalence and constraints of typhoid fever and its control in an endemic area of Singida region in Tanzania: lessons for effective control of the disease. J Public Health Epidemiol 2(5):93–99
56. Nsutebu EF, Martins P, Adiogo D (2003) Prevalence of typhoid fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon. Trop Med Int Health 8(6):575–578
57. Baker S, Dougan G (2007) The genome of Salmonella enterica serovar Typhi. Clin Infect Dis 45:S29–S33
58. Deng W, Liou SR, Plunkett G 3rd, Mayhew GF, Rose DJ, Burland V et al (2003) Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 185(7):2330–2337
59. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J et al (2001) Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848–852
60. McClelland M, Sanderson KE, Clifton SW, Latreille P, Porwollik S, Sabo A et al (2004) Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 36(12):1268–1274
61. Pickard D, Wain J, Baker S, Line A, Chohan S, Fookes M et al (2003) Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol 185:5055–5065
62. House D, Bishop A, Parry C, Dougan G, Wain J (2001) Typhoid fever: pathogenesis and disease. Curr Opin Infect Dis 14:573–578
63. Singh S (2001) Symposium: typhoid fever. Pathogenesis and laboratory diagnosis. J Indian Acad Clin Med 2(1):17–20
64. Raffatellu M, Wilson RP, Winter SE, Bäumler AJ (2008) Clinical pathogenesis of typhoid fever. J Infect Dev Ctries 2(4):260–266
65. Winter SE, Raffatellu M, Wilson RP, Rüssmann H, Bäumler AJ (2008) The Salmonella enterica serotype typhi regulator TviA reduces interleukin-8 production in intestinal epithelial cells by repressing flagellin secretion. Cell Microbiol 10:247–261
66. Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, Rüssmann H et al (2009) The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol Microbiol 74:175–193
67. Song J, Gao X, Galán JE (2013) Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature 499:350–354
68. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tükel C, Bäumler AJ (2008) The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 10:876–890
69. Ruby T, McLaughlin L, Gopinath S, Monack D (2012) Salmonella’s long-term relationship with its host. FEMS Microbiol Rev 36:600–615
70. Chakravortty D, Hansen-Wester I, Hensel M (2002) Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195:1155–1166
71. Tran QT, Gomez G, Khare S, Lawhon SD, Raffatellu M, Bäumler AJ et al (2010) The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect Immun 78:527–535
72. Kaur J, Jain SK (2012) Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis. Microbiol Res 167(4):199–210
73. McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V (2009) Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol 12:117–124
74. Smith SI, Fowora MA, Atiba A, Anejo-Okopi J, Fingesi T, Adamu ME et al (2015) Molecular detection of some virulence genes in Salmonella spp isolated from food samples in Lagos, Nigeria. Anim Vet Sci 3(1):22–27
75. Adesiji YO, Deekshit VK, Karunasagar I (2014) Antimicrobial-resistant genes associated with Salmonella spp. isolated from human, poultry, and seafood sources. Food Sci Nutr 2(4):436–442
76. Dione MM, Ikumapayi U, Saha D, Mohammed NI, Adegbola RA, Geerts S et al (2011) Antimicrobial resistance and virulence genes of non-typhoidal Salmonella isolates in the Gambia and Senegal. J Infect Dev Ctries 5:765–775
77. Karmi M (2013) Detection of virulence gene (invA) in Salmonella isolated from meat and poultry products. Int J Genet 3:07–12
78. Kupz A, Guarda G, Gebhardt T, Sander LE, Short KR, Diavatopoulos DA et al (2012) NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8(+) T cells. Nat Immun 13:162–169
79. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 192:227–236
80. Wain J, Hosoglu S (2008) The laboratory diagnosis of enteric fever. J Infect Dev Ctries 2:421–425
81. Keddy KH, Sooka A, Letsoalo ME, Hoyland G, Chaignat CL, Morrissey AB et al (2011) Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites. Bull World Health Organ 89:640–647. doi:10.2471/BLT.11.087627
82. Smith SI, Odunukwe NN, Niemogha MT, Ahmed AO, Efienemokwu CA, Otuonye MN et al (2004) Diagnostic methods for typhoid fever in Nigeria. Br J Biomed Sci 61(4):179–181
83. Mweu E, English M (2008) Typhoid fever in children in Africa. Trop Med Int Health 13(4):532–540
84. Otegbayo JA (2005) Typhoid fever: the challenges of medical management. Ann Ibadan Postgrad Stud 3(1):52–54
85. Olsen SJ, Pruckler J, Bibb W, Nguyen TM, Tran MT, Nguyen TM et al (2004) Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol 42(5):1885–1889
86. Ismail A (2000) New advances in the diagnosis of typhoid and detection of typhoid carriers. Malays J Med Sci 7(2):3–8
87. Krishna S, Desai S, Anjana VK, Paranthaaman RG (2011) Typhidot (IgM) as a reliable and rapid diagnostic test for typhoid fever. Am Trop Med Public health 4:42–44
88. Smith SI, Bamidele M, Fowora M, Goodluck HT, Omonigbehin EA, Akinsinde KA et al (2011) Application of a point-of-care test for the serodiagnosis of typhoid fever in Nigeria and the need for improved diagnostics. J Infect Dev Ctries 5(7):520–526
89. Storey HL, Huang Y, Crudder C, Golden A, de los Santos T, Hawkins K (2015) A meta-analysis of typhoid diagnostic accuracy studies: a recommendation to adopt a standardized composite reference. PLoS One 10(11), e0142364
90. Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B (2000) Salmonella nomenclature. J Clin Microbiol 38(7):2465–2467
91. Ugboko H, De N (2014) Mechanisms of antibiotic resistance in Salmonella typhi. Int J Curr Microbiol App Sci 3(12):461–476
92. Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid fever. Clin Infect Dis 50(2):241–246
93. Akinyemi KO, Coker AO (2007) Trends of antibiotic resistance in Salmonella enterica serovar Typhi isolated from hospitalized patients from 1997 to 2004 in Lagos, Nigeria. Indian J Med Microbiol 25:436–437
94. Makanjuola BO, Bakare RA, Fayemiwo SA (2012) Quinolone and multidrug resistant Salmonella typhi in Ibadan, Nigeria. Int J Trop Med 7(3):103–107
95. Akinyemi KO, Smith SI, Oyefolu AO, Coker AO (2005) Multidrug resistance in Salmonella enterica serovar Typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health 119(4):321–327
96. Mills-Robertson F, Addy ME, Mensah P, Crupper SS (2002) Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. FEMS Microbiol Lett 215:249–253
97. Dagnra AY, Akolly K, Gbadoe A, Aho K, David M (2007) Emergence of multidrug resistant Salmonella strains in Lome (Togo). Med Mal Infect 37:266–269
98. Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, Monroe SS et al (2012) Multidrug-resistant typhoid fever with neurologic findings on the Malawi–Mozambique border. Clin Infect Dis 54(8):1100–1106
99. Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL (2015) Typhoid fever. Lancet 385:1136–1145
100. Slayton RB, Date KA, Mintz ED (2013) Vaccination for typhoid fever in sub-Saharan Africa. Hum Vaccin Immunother 9(4):903–906
101. Turner AK, Nair S, Wain J (2006) The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58(4):733–740
102. Keddy KH, Smith AM, Sooka A, Ismail H, Oliver S (2010) Fluoroquinolone-resistant typhoid, South Africa. Emerg Infect Dis 16(5):879–880
103. Baltazar M, Ngandjio A, Holt KE, Lepillet E, Pardos de la Gandara M, Collard JM et al (2015) Multidrug-resistant Salmonella enterica serotype Typhi, Gulf of Guinea Region, Africa. Emerg Infect Dis 21(4):655–659
104. Feasey NA, Gaskell K, Wong V, Msefula C, Selemani G, Kumwenda S et al (2015) Rapid emergence of multidrug resistant, H58-lineage Salmonella typhi in Blantyre, Malawi. PLoS Negl Trop Dis 9(4):e0003748
105. World Health Organization (WHO) (2003) The diagnosis, treatment and prevention of typhoid fever. WHO, Geneva
106. Verma R, Bairwa M, Chawla S, Prinja S, Rajput M (2011) New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries. Hum Vaccin 7:883–885